Nowtransit INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

Bioscience Health Innovations, Inc. announces the resignation of director Justin Earl and the appointment of CTO Daniel Schmidt to the Board.
BioScience Health Innovations, Inc. completed a 4-for-1 reverse stock split effective September 10, 2025, consolidating its common shares.
BioScience Health Innovations, Inc. (formerly Nowtransit, Inc.) officially changed its name and amended its bylaws to reflect the new corporate identity, effective February 21, 2025.
Nowtransit Inc. has completed a reverse merger with Best Labs, Inc., acquiring a portfolio of health and wellness products and changing its business focus.
Nowtransit Inc. has changed its independent registered public accounting firm from Spiegel Accountancy Corp to Mac Accounting Group & CPAs LLP following a reverse merger with Best 365 Labs, LLC.